CR = complete response PD = progressive disease
PR = partial response SD = stable disease
Treatment Table
Sample | Response | IPI IDs | Primary site | Stage | Pre/Post anti-PD-1 Treatment | Prior Ipilimumab | Prior Targeted Therapy | Prior Radiation | Prior Chemotherapy | Baseline LDH |
---|---|---|---|---|---|---|---|---|---|---|
1 | CR | IPIMEL035 | Cutaneous | IV | Post | Y | Y | Y | N | Normal |
2 | CR | IPIME | L076Cutaneous | IIIC | Pre | N | N | N | N | Normal |
3 | CR | IPIMEL105_T2 | Cutaneous | IIIC | Post | N | N | N | N | Normal |
4 | CR | IPIMEL125 | Cutaneous | IIIB | Post | N | N | N | N | Normal |
5 | CR | IPIMEL134 | Cutaneous | IIIB | Post | N | Y | N | N | Normal |
6 | CR | IPIMEL181 | Cutaneous | IV | Pre | N | N | N | N | Normal |
7 | CR | IPIMEL253 | LN | IV | Post | N | N | N | N | Elevated |
8 | CR | IPIMEL274 | LN | IV | Post | N | Y | Y | N | Normal |
9 | CR | IPIMEL276 | Cutaneous | IIIB | Post | N | Y | N | N | Normal |
10 | CR | IPIMEL288 | Cutaneous | IIIA | Pre | N | N | N | N | Normal |
11 | PR | IPIMEL085 | Unknown | IV | Pre | Y | N | Y | N | Normal |
12 | PR | IPIMEL090 | Unknown | IV | Post | Y | N | N | N | Normal |
13 | PR | IPIMEL106 | Cutaneous | IV | Pre | N | Y | Y | N | Normal |
14 | PR | IPIMEL108 | Melanoma Primary | IV | Pre | N | N | N | N | Normal |
15 | PR | IPIMEL127 | Mucosal | IV | Post | Y | N | N | N | Elevated |
16 | PR | IPIMEL131 | Cutaneous | IV | Pre | N | N | N | N | Normal |
17 | SD | IPIMEL116_T1 | Unknown | IV | Post | N | N | Y | N | Normal |
18 | SD | IPIMEL156 | Cutaneous | IV | Post | N | N | N | N | Elevated |
19 | SD | IPIMEL185 | Cutaneous | IV | Pre | N | N | N | N | Elevated |
20 | PD | IPIMEL044 | Cutaneous | IV | Post | Y | N | N | N | Normal |
21 | PD | IPIMEL123_T1 | Cutaneous | IV | Pre | N | N | N | N | Normal |
22 | PD | IPIMEL147 | Cutaneous | IV | Pre | N | N | N | N | Normal |
23 | PD | IPIMEL149 | Cutaneous | IV | Post | Y | Y | N | N | Normal |
24 | PD | IPIMEL155 | Cutaneous | IIIA | Pre | N | N | N | N | N/A |
25 | PD | IPIMEL191 | Cutaneous | IIIA | Pre | N | Y | N | N | Normal |
26 | PD | IPIMEL226 | Cutaneous | IV | Post | Y | Y | N | N | N/A |
27 | N/A | IPIMEL056 | Cutaneous | IV | N/A | N | N | N | N | N/A |
28 | N/A | IPIMEL221 | Skin and Soft Tissue | N/A | N/A | N | N | N | N | N/A |
29 | N/A | IPIMEL212 | Left axillary lymph nodes, | IIIC | N/A | N | N | N | N | N/A |
30 | N/A | IPIMEL069 | Cutaneous | III | N/A | N | N | N | N | N/A |
31 | N/A | IPIMEL113 | Merkel Cell Carcinoma w/ extensive associated subcutaneous invasion |
IIIA | N/A | N | N | N | N | N/A |
ID Table
Sample | Response | IPI IDs | GEO link for RNAseq Fastgs | Used for heatmap |
WSPs available |
---|---|---|---|---|---|
1 | CR | IPIMEL035 | N/A | ||
2 | CR | IPIMEL076 | X | x | |
3 | CR | IPIMEL105_T2 | X | x | |
4 | CR | IPIMEL125 | X | x | |
5 | CR | IPIMEL134 | N/A | ||
6 | CR | IPIMEL181 | X | x | |
7 | CR | IPIMEL253 | GSM3097446 | X | x |
8 | CR | IPIMEL274 | GSM3097447 | X | x |
9 | CR | IPIMEL276 | X | x | |
10 | CR | IPIMEL288 | X | x | |
11 | PR | IPIMEL085 | GSM3097440 | X | x |
12 | PR | IPIMEL090 | X | x | |
13 | PR | IPIMEL106 | X | x | |
14 | PR | IPIMEL108 | GSM3097441 | X | x |
15 | PR | IPIMEL127 | X | x | |
16 | PR | IPIMEL131 | GSM3097443 | X | x |
17 | SD | IPIMEL116_T1 | X | x | |
18 | SD | IPIMEL156 | X | x | |
19 | SD | IPIMEL185 | X | x | |
20 | PD | IPIMEL044 | N/A | x | |
21 | PD | IPIMEL123_T1 | X | x | |
22 | PD | IPIMEL147 | X | x | |
23 | PD | IPIMEL149 | GSM3097444 | X | x |
24 | PD | IPIMEL155 | X | x | |
25 | PD | IPIMEL191 | X | x | |
26 | PD | IPIMEL226 | X | x | |
27 | N/A | IPIMEL056 | GSM3097438 | N/A | X |
28 | N/A | IPIMEL221 | GSM3097448 | N/A | X |
29 | N/A | IPIMEL212 | GSM3097445 | N/A | X |
30 | N/A | IPIMEL069 | GSM3097439 | N/A | x |
31 | N/A | IPIMEL113 | GSM3097442 | N/A | x |
Flow Fraction Table
# = very low cell count
Sample | Response | IPI IDs | cDC1/HLA DR+ Lin- | Nk cells/CD45+ | cDC2/HLA DR+ Lin- | CD4 Tconv/CD45+ | CD4 Treg/CD45+ | CD8 T cell/CD45+ |
---|---|---|---|---|---|---|---|---|
1 | CR | IPIMEL035 | 1.51 | 1.53 | 3.66 | N/A | N/A | N/A |
2 | CR | IPIMEL076 | 2.82 | 2.06 | 10.7 | 24.3 | 3.02 | 50 |
3 | CR | IPIMEL105_T2 | 1.56 | 0.65 | 9.41 | 74.2 | 1.74 | 18.9 |
4 | CR | IPIMEL125 | 2.62 | 0.54 | 9.07 | 78.3 | 12.3 | 8.02 |
5 | CR | IPIMEL134 | 2.57 | N/A | N/A | N/A | N/A | N/A |
6 | CR | IPIMEL181 | 2.51 | 1.29 | 22.2 | 63.7 | 11.5 | 14.5 |
7 | CR | IPIMEL253 | 2.51 | 2.55 | 7.9 | 51.3 | 8.33 | 18 |
8 | CR | IPIMEL274 | 5.35 | 1.22 | 5.23 | 33.1 | 11.8 | 48.7 |
9 | CR | IPIMEL276 | 0.53 | 3.25 | 12.5 | 12.3 | 8.02 | 4.77 |
10 | CR | IPIMEL288 | 2.13 | 2.17 | 21.6 | 65.2 | 9.42 | 17 |
11 | PR | IPIMEL085 | 2.79 | 1 | 29.9 | 81.4 | 6.98 | 7.32 |
12 | PR | IPIMEL090 | 1.07 | 0.46 | 17.2 | 62.5 | 2.53 | 29 |
13 | PR | IPIMEL106 | 5.59 | 5.99 | 2.8 | 34.8 | 4.93 | 43 |
14 | PR | IPIMEL108 | 2.41 | 2.78 | 9.13 | 7.06 | 0.75 | 5.81 |
15 | PR | IPIMEL127 | 5.19 | 6.76 | 12.5 | 19.4 | 12.9 | 37.9 |
16 | PR | IPIMEL131 | 3.05 | 3.74 | 4.57 | 26.1 | 1.6 | 56.9 |
17 | SD | IPIMEL116_T1 | 0.44 | 0.53 | 0.64 | 5.48 | 2.44 | 2.91E-03 |
18 | SD | IPIMEL156 | 0.95 | 1.26 | 4.25 | 6.68 | 1.07 | 0.11 |
19 | SD | IPIMEL185 | #1.56 | #3.04 | #6.77 | #0.039 | #0.061 | #0.005 |
20 | PD | IPIMEL044 | 1.35 | N/A | 16.2 | N/A | N/A | N/A |
21 | PD | IPIMEL123_T1 | 1.68 | 0.53 | 14 | 56.4 | 6.75 | 29 |
22 | PD | IPIMEL147 | 0.37 | 0.09 | 18.9 | 0.1 | 0.023 | 6.40E-01 |
23 | PD | IPIMEL149 | 0.29 | 0.92 | 6.66 | N/A | N/A | N/A |
24 | PD | IPIMEL155 | 0.4 | N/A | 7.63 | N/A | N/A | N/A |
25 | PD | IPIMEL191 | 0.96 | 0.68 | 10.3 | 36.7 | 1.21 | 6.51 |
26 | PD | IPIMEL226 | 0.9 | 1.23 | 4.56 | 17.7 | 9.36 | 68 |
27 | N/A | IPIMEL056 | 1.49 | 0.77 | 5.7 | N/A | N/A | N/A |
28 | N/A | IPIMEL221 | 0.44 | 0.6 | 0.76 | N/A | N/A | N/A |
29 | N/A | IPIMEL212 | 4.24 | 2.23 | 13.1 | N/A | N/A | N/A |
30 | N/A | IPIMEL069 | 0.29 | 0.6 | 0.83 | N/A | N/A | N/A |
31 | N/A | IPIMEL113 | 3.13 | 3.6 | 24.3 | N/A | N/A | N/A |